Regeneron Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
REGN
CUSIP
75886F107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 75886F107 since 12/18/2024, newest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 7.4% 4/30/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 7 0% 3/27/2026
Event 3/13/2026
FMR LLC 13G/A Amendment 7
3.2% 8/6/2025
Event 6/30/2025
JPMorgan Chase & Co 13G/A Amendment 3 4.4% 6/5/2025
Event 5/30/2025
JPMorgan Chase & Co 13G/A Amendment 2 5.1% 4/22/2025
Event 3/31/2025
FMR LLC 13G/A Amendment 6
7.6% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 123 497 k $367 M
2026 Q2 1,415 189 M $58.4 B
2026 Q1 1,476 90.5 M $69.8 B
2025 Q4 1,474 91.9 M $70.9 B
2025 Q3 1,329 91.2 M $51.3 B
2025 Q2 1,294 90.6 M $47.6 B
2025 Q1 1,373 93.5 M $59.2 B
2024 Q4 1,420 93.7 M $66.8 B
2024 Q3 1,486 102 M $106 B
2024 Q2 1,424 104 M $109 B
2024 Q1 1,408 104 M $99.4 B
2023 Q4 1,361 100 M $88.1 B
2023 Q3 1,259 91.3 M $75.2 B
2023 Q2 1,241 92.7 M $66.2 B
2023 Q1 1,266 99.2 M $76.2 B
2022 Q4 1,229 99.3 M $70.9 B
2022 Q3 1,155 93.4 M $64.4 B
2022 Q2 1,129 93.5 M $55.2 B
2022 Q1 1,165 93.0 M $64.8 B
2021 Q4 1,150 90.9 M $57.3 B
2021 Q3 1,087 90.4 M $54.5 B
2021 Q2 1,036 89.2 M $49.8 B
2021 Q1 982 89.8 M $42.4 B
2020 Q4 978 91.6 M $44.8 B
2020 Q3 973 92.4 M $51.8 B
2020 Q2 998 93.1 M $58.0 B
2020 Q1 890 76.2 M $37.1 B
2019 Q4 766 75.3 M $28.3 B
2019 Q3 695 74.5 M $20.6 B
2019 Q2 740 74.6 M $23.3 B
2019 Q1 785 74.1 M $30.4 B
2018 Q4 736 74.4 M $27.8 B
2018 Q3 723 75.2 M $30.4 B
2018 Q2 693 73.3 M $25.3 B
2018 Q1 691 73.6 M $25.3 B
2017 Q4 712 71.6 M $26.9 B
2017 Q3 676 72.4 M $32.4 B
2017 Q2 668 73.1 M $35.9 B
2017 Q1 644 72.3 M $28.0 B
2016 Q4 649 72.2 M $26.5 B
2016 Q3 616 73.6 M $29.6 B
2016 Q2 605 72.6 M $25.4 B
2016 Q1 596 79.7 M $26.2 B
2015 Q4 635 73.9 M $42.5 B
2015 Q3 610 75.4 M $37.1 B
2015 Q2 588 73.9 M $37.7 B
2015 Q1 545 73.1 M $33.0 B
2014 Q4 560 72.8 M $30.0 B
2014 Q3 509 71.7 M $27.9 B
2014 Q2 482 75.2 M $21.6 B
2014 Q1 489 73.5 M $22.3 B